-
Denileukin diftitox, sold
under the
brand name
Ontak among others, is an anti-cancer
medication used for the
treatment of
adults with T-cell lymphoma....
- of cancer, like
nasopharyngeal carcinoma.
Eisai markets a drug
called denileukin diftitox (trade name Ontak),
which is a
recombinant fusion protein of...
- has been
approved in ****an and the
United States. The FDA has
approved denileukin diftitox-cxdl (Lymphir) for the
treatment of
patients with relapsed/refractory...
- Pharmaceuticals,
including the
chemotherapy medications gemcitabine and
denileukin diftitox, as well as
certain interleukins and
monoclonal antibodies, can...
-
lysogenic phage (corynephage β)
infecting all
toxigenic strains. The drug
denileukin diftitox uses
diphtheria toxin as an
antineoplastic agent.
Resimmune is...
-
earlier stages. FDA
approved treatments include the following: (1999)
Denileukin diftitox (Ontak) (2000)
Bexarotene (Targretin) a
retinoid (2006) Vorinostat...
-
Brexucabtagene autoleucel Celecoxib Ciltacabtagene autoleucel Demecolcine Denileukin diftitox Eflornithine Elesclomol§
Elsamitrucin Epacadostat Eribulin Estramustine...
-
disorders like
rheumatoid arthritis,
psoriatic arthritis, and psoriasis.
Denileukin-diftitox:
Treats cutaneous lymphoma. A
recombinant fusion protein is a...
- L01XX23
Mitotane L01XX24
Pegaspargase L01XX27 ****nic
trioxide L01XX29
Denileukin diftitox L01XX33
Celecoxib L01XX35
Anagrelide L01XX36
Oblimersen L01XX40...
- However,
bacterial toxins, such as
diphtheria toxin,
which is used in
denileukin diftitox, an FDA-approved
treatment for
leukemia and lymphoma, have proven...
